Study Evaluating The Tolerability Of Multiple Doses Of HKI-272

Completed · Phase 1

Conditions studied: Healthy Subjects

In brief

Study to investigate the occurence of diarrhea after either once daily or twice daily dosing for 14 days.

Key facts

Study ID

NCT00757809

Run by

Puma Biotechnology, Inc.

People needed

50

Starts

2008-10-01

Expected to finish

2008-10-01

Last updated by the study team

2012-05-14

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female (non-child bearing potential) subjects
• Ages 18-50.

Where it is running

• Study site — Austin, Texas, United States
• Study site — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.